Accella Advisors


BridgeServices for Investors

Most venture funds have a company portfolio with a wide range of technologies. Considering the fast development of new technologies and therapeutic approaches, it is sometimes difficult to have sufficient in-house expertise for a proper evaluation of potential investment candidates.

We have a comprehensive experience in the scientific and commercial evaluation of new business ideas and – through our long-term professional experience – we are used to look at both sides of the story, i.e. from the investors point of view and from big pharma.

We offer:   Comprehensive company due diligence
competitive landscape
commercial potential
management audit
Company and portfolio valuation
Turnaround and crisis management
Assumption of management roles (CEO, CSO)

Services for Non-European Pharma and Biotech Companies